title: Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
authors.forename: Margaret K
authors.initials: MK
authors.lastname: Hahn
authors.forename: Tony
authors.initials: T
authors.lastname: Cohn
authors.forename: Gary
authors.initials: G
authors.lastname: Remington
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008687:Metformin / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*; D000077236:Topiramate; D015430:Weight Gain / Q000187:drug effects
chemical_list: D019440:Anti-Obesity Agents; D014150:Antipsychotic Agents; D000077236:Topiramate; D005632:Fructose; D008687:Metformin